Jerusalem, 3 October 2022 /PRNewswire/ — Olive Diagnostics, an IoMT medtech startup that makes use of AI for 100% passive urine evaluation, introduced that it has obtained the CE Mark Europe For Olive KG, the world’s first hands-free, non-invasive, AI-based optical system for 100% passive and seamless urinalysis, mounted on any rest room.
Olive KG performs top quality evaluation of important parameters in sufferers’ urine at every urination with out consumer intervention. The consumer does nothing greater than pee in the bathroom the best way they’ve been all their lives. Amongst different parameters, the system measures pink blood cells, proteins, nitrites, pH degree, in addition to traits equivalent to quantity, strain, coloration and frequency of urination. The system makes use of optics to detect molecular parts in urine, and generates real-time private knowledge, secured in accordance with GDPR and HIPPA necessities, which is shipped to the cloud after which to the treating doctor. The corporate can also be within the pre-submission stage for the FDA United States,
Olive Diagnostics is promoting its units as we speak by way of assisted dwelling amenities, outpatient amenities and telemedicine suppliers Europe To current the parameters that can be utilized to diagnose the event of illnesses early. This can immediately cut back the working value by decreasing the price of hospitalization. KG may present distant medical data to relations and caregivers to detect the chance of situations equivalent to dehydration and to offer perception about bowel actions.
The continual monitoring nature of the Olive Diagnostics system alerts customers to pre-symptomatic points, generally weeks earlier than signs and the presence of situations together with urinary tract infections (UTIs) and kidney stones. When the chance of a UTI-like situation is marked, prophylactic medicine could also be administered, a functionality that will cut back the chance of hospitalization. For males, kidney stones might be detected weeks earlier than the onset of painful signs in order that they are often simply handled earlier than hospitalization. This makes the startup’s software a helpful software for the aged, the place early detection can enhance high quality of life and high quality of care.
“The milestone of reaching CE marking supplies recognition for our imaginative and prescient and know-how and paves the best way for us to enter the European market,” stated Man GoldmanCEO of Olive Diagnostics. “Olive KG is already put in in lots of assisted dwelling amenities HollandAnd we imagine our system will rework medical care into non-invasive prevention, serving to sufferers and healthcare suppliers detect illnesses earlier than signs seem.”
About Olive Diagnostics
Olive Diagnostics was based in 2019 by Man Goldman (CEO) and Corey Katzo, The startup’s crew consists of specialists in biochemistry, chemistry, physics, knowledge analytics, optics and enterprise improvement for the well being and wellness markets. Olive Diagnostics can also be within the FDA pre-submission stage for this United States,
The corporate has raised seed financing $7.3 millionNot too long ago after elevating an addition $1.5 million From current traders and personal traders. Buyers within the pre-seed stage embody Israeli HMO Maccabi Healthcare Companies, Mayo Clinic, eHealth Ventures, Amgen Ventures, The Israel Innovation Authority, together with personal European and US personal traders.
Pictures might be downloaded right here.
Amir Ben Artzik
Supply Olive Diagnostics